Waldenstrom-associated anti-MAG paraprotein polyneuropathy with neurogenic tremor

BMJ Case Rep. 2019 Mar 31;12(3):e228376. doi: 10.1136/bcr-2018-228376.

Abstract

A 71-year-old female patient presented with a 14-year history of slowly progressive distal limb numbness, paraesthesia and reduced vibration perception, ataxic gait and intentional tremor. Examination revealed with a length-dependent sensory neuropathy. Nerve conduction studies showed a chronic sensorimotor inflammatory demyelinating polyneuropathy. Intravenous immunoglobulin treatment (on two occasions) proved ineffective. Serum electrophoresis showed increased monoclonal IgM with kappa light chains. Anti-myelin-associated glycoprotein (MAG) levels were extremely elevated, >70 000 BTU. Bone marrow biopsy revealed 15%-20% small B cells and positive MYD88 mutation, indicative of Waldenstrom macroglobulinaemia. A diagnosis of Waldenstrom-associated anti-MAG paraprotein neuropathy with intentional (neurogenic) tremor was made. Repeat nerve conduction study showed a severe sensory demyelinating neuropathy with no axonal lesion. Treatment with rituximab was given for 1 month with minimal improvement. Repeat anti-MAG levels dropped to 53 670 BTU, with minimal clinical improvement.

Keywords: neurology; peripheral nerve disease.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Female
  • Gait Ataxia / etiology
  • Humans
  • Immunoglobulin M / therapeutic use
  • Immunologic Factors / therapeutic use*
  • Myelin-Associated Glycoprotein / metabolism*
  • Paraproteins / metabolism
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / diagnosis*
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / drug therapy
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / physiopathology
  • Rituximab / therapeutic use*
  • Treatment Outcome
  • Tremor / etiology
  • Waldenstrom Macroglobulinemia / diagnosis*
  • Waldenstrom Macroglobulinemia / drug therapy
  • Waldenstrom Macroglobulinemia / physiopathology

Substances

  • Immunoglobulin M
  • Immunologic Factors
  • MAG protein, human
  • Myelin-Associated Glycoprotein
  • Paraproteins
  • Rituximab